5DK3
Crystal Structure of Pembrolizumab, a full length IgG4 antibody
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2014-05-21 |
| Detector | MARMOSAIC 300 mm CCD |
| Wavelength(s) | 1.00 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 63.830, 110.830, 264.960 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 33.380 - 2.280 |
| R-factor | 0.1863 |
| Rwork | 0.184 |
| R-free | 0.22350 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.180 |
| Data reduction software | XDS |
| Data scaling software | Aimless (0.1.27) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.5) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 110.830 | 110.830 | 2.550 |
| High resolution limit [Å] | 2.280 | 5.090 | 2.280 |
| Rmerge | 0.072 | 0.032 | 0.723 |
| Rpim | 0.013 | 0.282 | |
| Total number of observations | 56298 | 184254 | |
| Number of reflections | 654220 | ||
| <I/σ(I)> | 18.5 | 46.7 | 3 |
| Completeness [%] | 100.0 | 100 | 100 |
| Redundancy | 3.8 | 6.8 | 7.5 |
| CC(1/2) | 0.999 | 0.857 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 8.5 | 303 | 1.8-2.2 M NH4H2PO4, 100 mM TRIS |






